Diagnostic.ly Unveils New At-Home Diagnostics Capabilities To Automate Test & Treat, Treat & Prove Care

Global Diagnostics Technologies LLC (doing business as [dba] Diagnostic.ly) announced a platform expansion that enables health care organizations to automate clinical responses to diagnostic results, detect specimen collection failures in real time, and provide independent laboratories with competitive insights. The new capabilities are available now to the company's partners.

The expansion includes tools supporting “Test & Treat” and “Treat & Prove” workflows. Health care organizations can use these tools to automate treatment recommendations following a diagnostic result, as well as automate follow-up testing to measure the efficacy of supplements, hormones, and peptides.

Diagnostic.ly also introduced a . . .